Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
2024/11/06
Building a culture of quality, jointly creating a high-quality enterprise | Wanbande Pharmaceutical Group’s 7th “Quality Month” event successfully concluded!
2024/10/26
The Zhejiang University Children's Hospital team’s latest research findings: Huperzine A shows promise in treating diabetic nephropathy.
2024/09/29
Building a culture of quality, jointly creating a high-quality enterprise | Wanbande Pharmaceutical Group’s 7th “Quality Month” event kick-off meeting successfully held!
2024/08/29
Warmest congratulations! | Wanbangde Pharmaceutical Group Wins Award at the Provincial Brand Story Competition!
2024/08/06
Science Up Close, Innovation Shaping the Future | Celebrating Wanbande Pharmaceutical Group’s Support for Wenling City’s New-Era Civilization Practice Center Summer Camp—A Hands-On Learning Experience at Local Enterprises
2024/07/03
Named for five consecutive years | Warmest congratulations to Wanbang Xinnuokang® Ginkgo Leaf Droplets for being selected on the "2024 China Pharmaceutical Brand List"!
2024/06/27
Safety Production Month | Absolutely Thrilling! Wanbangde Pharmaceutical Group Successfully Holds 2024 "Emergency Rescue Skills" Competition
Employee Activities | "Rope" Dynamics Unleashed: Showcasing Strength and Spirit, Dancing with Passion to Create Brilliance
News | Workshop on Projects Including Wande Pharmaceutical Group's Academician Expert Workstation and Huperzine A Controlled-Release Tablets Successfully Held
Employee Activity | Discover the Charm of Intangible Cultural Heritage, Enjoy the Fun of Bamboo Weaving, and Together "Craft" Beautiful Fans!
"Everyone Talks Safety, Everyone Knows How to Respond—Keeping Life Paths Clear" | Wanbangde Pharmaceutical Group Holds 2024 "Safety Production Month" Kickoff Meeting
2024/06/03
[Literature Review] Huperzine A Improves Neurological Deficits After Spontaneous Subarachnoid Hemorrhage by Inhibiting Endothelial Cell Pyroptosis
Tech Month | Step into Wanbangde Pharmaceutical, get up close with scientific research, and embark together on a journey of pharmaceutical exploration.
Warmest congratulations! | Wanbangde Pharmaceutical Group’s Academician Workstation has been officially awarded the title of "Provincial-Level Key Academician Workstation"—the official plaque ceremony has taken place!
Good News | Wanbangde Pharmaceutical Group’s Huperzine A Granted Orphan Drug Designation by the U.S. FDA for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy!
